Explore PMOS Research
Search 20,710 PMOS papers published between 2015 and 2025. Filter by research topic, country, year range, or co-investigated condition to find where the field is active and where the gaps are.
Total citations
289,983
Peak year
2025(3,021 articles)
Avg citations / article
14
Publications per year
Topics
All research areas ⓘArticle mentionsA paper tagged with multiple topics counts once in each. The Overview uses fractional counting instead. See methodology.
Countries
All countries
Top journals
All filters
Top institutions
All filters
Where in the world is each topic being researched?
Toggle between Revealed Comparative Advantage (RCA), a specialisation index where values above 1.0 mean a country focuses on that topic more than average, and raw article counts.
| Hormones | Metabolic | Fertility | Epidemiol. | Pharma | Diagnos. | Genetics | Mental | Nutrition | Molecular | Inflamm. | Cell Bio | Lifestyle | Microbiome | Dermatol. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| China | 1.0 | 0.9 | 1.1 | 0.9 | 1.1 | 0.7 | 1.5 | 0.4 | 0.7 | 1.9 | 1.1 | 2.1 | 0.5 | 1.4 | 0.2 |
| United States | 1.0 | 1.1 | 1.0 | 1.3 | 0.8 | 1.1 | 0.9 | 1.4 | 0.6 | 0.6 | 0.7 | 0.6 | 1.0 | 0.6 | 1.3 |
| India | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 1.9 | 1.1 | 1.1 | 1.7 | 0.8 | 0.7 | 0.6 | 1.2 | 1.2 | 1.9 |
| Iran | 1.0 | 0.9 | 0.9 | 0.9 | 1.6 | 0.5 | 0.7 | 1.2 | 1.8 | 0.9 | 2.0 | 0.7 | 1.1 | 0.9 | 0.8 |
| Turkey | 1.2 | 1.2 | 0.8 | 0.4 | 0.4 | 1.4 | 0.5 | 1.0 | 1.0 | 0.6 | 1.7 | 0.5 | 0.4 | 1.3 | 1.4 |
| United Kingdom | 0.9 | 1.0 | 0.9 | 1.3 | 1.0 | 0.9 | 0.8 | 2.0 | 0.9 | 0.5 | 0.7 | 0.3 | 1.8 | 0.5 | 1.3 |
| Australia | 0.8 | 1.1 | 0.9 | 1.9 | 1.1 | 0.8 | 0.6 | 2.1 | 0.7 | 0.2 | 0.1 | 0.5 | 4.0 | 0.4 | 0.5 |
| Italy | 1.1 | 1.2 | 1.0 | 0.8 | 0.9 | 1.2 | 0.5 | 0.8 | 1.5 | 0.6 | 0.7 | 0.3 | 0.5 | 1.0 | 1.0 |
| Egypt | 1.0 | 0.8 | 1.9 | 0.4 | 1.7 | 0.8 | 0.4 | 0.6 | 1.1 | 0.6 | 1.0 | 0.5 | 0.3 | 0.3 | 2.2 |
| Poland | 1.3 | 1.4 | 0.5 | 0.6 | 0.4 | 0.8 | 0.6 | 1.2 | 0.8 | 0.6 | 1.2 | 0.4 | 1.1 | 1.7 | 1.6 |
Studies8,141–8,160 of 20,710
All studies
Successful Pregnancy in Morbidly Obese Women of Polycystic Ovary Syndrome With Various Treatment Options With Individual Consequences: Case Series
ADDING L-CARNITINE AND VITAMIN D TO LETROZOLEIN OVULATION INDUCTION IN PCOS PATIENTS
A Qualitative Study of Barriers and Facilitators to Polycystic Ovary Syndrome TreatmentAdherence: Iranian Context
Cancer risk in polycystic ovary syndrome patients: Common treatments and future perspectives
Retraction notice to “Combined coenzyme Q10 and clomiphene citrate for ovulation induction in clomiphene-citrate-resistant polycystic ovary syndrome” RBMO 29/1 (2014) 119-124
Early-onset metabolic syndrome and cardiovascular risk in polycystic ovary syndrome
Nutritional Management of Infertility in Patients with Polycystic Ovary Syndrome
Pelvic MRI Evaluation of Polycystic Ovary Syndrome in Reproductive-Age Women: A Cross-Sectional Study
Prevalence of Psychological Disorders in Women with Polycystic Ovary Syndrome
Mental health latent profiles and emotion regulation in women with polycystic ovary syndrome: a cross-sectional study
Cardiometabolic Complications of PCOS
Characteristics of Body Composition in Different Phenotypes of South Indian Women with Polycystic Ovary Syndrome and Relation with Body Image and Psychological Profile
Exploring the Potential Effect Study of Morinda citrifolia and PCOS Based on Network Pharmacology
A comprehensive transethnic metabolomic analysis in women with PCOS in the born in bradford (BiB) study
Metabolic and Cardiovascular Risks in Women with Polycystic Ovary Syndrome: Focus on Type 2 Diabetes, MASLD, and Cardiovascular Disease
SAT386 Constitutive Overexpression Of Microrna-93 As A Cause Of Metabolic Dysfunction And Hyperandrogenism In Polycystic Ovary Syndrome (PCOS): Evidence From A Transgenic (Mir-93+) Murine Model
Systemic and local pharmacological effects of melatonin targeting polycystic ovary syndrome based on network pharmacology
SAT387 Impact Of Genetic Background On Chronic Inflammation In A Letrozole-induced Mouse Model Of PCOS
Visfatin as a potential cardiometabolic risk factor in women with polycystic ovary syndrome